Skeletal metastasis in renal cell carcinoma: Current and future management options
Cancer Treatment Reviews2011Vol. 38(4), pp. 284–291
Citations Over TimeTop 10% of 2011 papers
Related Papers
- → Differences between zoledronic acid and denosumab for breast cancer treatment(2023)15 cited
- → Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab(2016)9 cited
- → Breast cancer bone metastases: denosumab or zoledronic acid?(2011)4 cited
- → Trends in the use of bone agents in metastatic cancer.(2013)
- → [Incidence of Antiresorptive Agent-Related Osteonecrosis of the Jaw in Urologic Cancers].(2022)